S
ITCI

SignatureFD’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

SignatureFD’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-813
Closed -$107K – 3475
2025
Q1 		$107K Buy
813
+237
+41% +$29.5K ﹤0.01% 1176
2024
Q4 		$48.1K Buy
576
+38
+7% +$3.12K ﹤0.01% 1613
2024
Q3 		$39.4K Buy
538
+8
+2% +$601 ﹤0.01% 1713
2024
Q2 		$36.3K Buy
530
+54
+11% +$3.75K ﹤0.01% 1671
2024
Q1 		$32.9K Sell
476
-42
-8% -$2.89K ﹤0.01% 1760
2023
Q4 		$37.1K Buy
518
+239
+86% +$13.7K ﹤0.01% 1615
2023
Q3 		$14.5K Sell
279
-71
-20% -$4.14K ﹤0.01% 2018
2023
Q2 		$22.2K Buy
350
+60
+21% +$3.74K ﹤0.01% 1831
2023
Q1 		$15.7K Buy
290
+22
+8% +$1.06K ﹤0.01% 2002
2022
Q4 		$14.2K Buy
268
+128
+91% +$6.42K ﹤0.01% 1968
2022
Q3 		$7K Buy
140
+54
+63% +$2.82K ﹤0.01% 2293
2022
Q2 		$5K Sell
86
-155
-64% -$8.79K ﹤0.01% 2478
2022
Q1 		$15K Buy
241
+141
+141% +$7.32K ﹤0.01% 1988
2021
Q4 		$5K Buy
100
+34
+52% +$1.43K ﹤0.01% 2440
2021
Q3 		$2K Sell
66
-9
-12% -$313 ﹤0.01% 2727
2021
Q2 		$3K Buy
75
+45
+150% +$1.66K ﹤0.01% 2505
2021
Q1 		$1K Buy
+30
New +$1.04K ﹤0.01% 2709

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SignatureFD's ITCI Position: Q2 2025 in Review

SignatureFD sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 813 shares — an estimated $107K sold.

SignatureFD first reported a position in ITCI in Q1 2021 and held it in 17 quarters. The position peaked at $107K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • SignatureFD reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • SignatureFD sold 813 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $107K.
  • SignatureFD first reported a position in Intra-Cellular Therapies Inc. in Q1 2021 and held it in 17 quarters.
  • SignatureFD's Intra-Cellular Therapies Inc. position peaked at $107K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on SignatureFD's 13F filing for Q2 2025, filed 16 Jul 2025.